These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21061099)

  • 1. Is testing for antiphosphatidylethanolamine antibodies clinically useful?
    Sanmarco M
    Curr Rheumatol Rep; 2011 Feb; 13(1):81-5. PubMed ID: 21061099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of antiphosphatidylethanolamine antibodies in the so-called "seronegative antiphospholipid syndrome".
    Sanmarco M
    Autoimmun Rev; 2009 Dec; 9(2):90-2. PubMed ID: 19306951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seronegative Antiphospholipid Syndrome with Anti-phosphatidylethanolamine Antibody in a Boy.
    Asano T; Narazaki H; Kaizu K; Kuwabara K; Fujino O; Itoh Y
    J Nippon Med Sch; 2015; 82(2):117-20. PubMed ID: 25959205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of antiphosphatidylethanolamine antibodies in the diagnosis of the antiphospholipid syndrome.
    Sanmarco M; Bardin N
    Lupus; 2012 Jun; 21(7):727-8. PubMed ID: 22635214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Which place of antiphosphatidylethanolamine antibodies research in seronegative antiphospholipid syndrome suspicion?].
    Billoir P; Miranda S; Abboud J; Armengol G; Levesque H; Benhamou Y; Le Cam Duchez V
    Rev Med Interne; 2019 Jun; 40(6):351-354. PubMed ID: 30905593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New autoantigens in the antiphospholipid syndrome.
    Alessandri C; Conti F; Pendolino M; Mancini R; Valesini G
    Autoimmun Rev; 2011 Aug; 10(10):609-16. PubMed ID: 21545849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and antiphospholipid syndrome in cancer: Uninvited guests in troubled times.
    Islam MA
    Semin Cancer Biol; 2020 Aug; 64():108-113. PubMed ID: 31351197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seronegative antiphospholipid syndrome.
    Nayfe R; Uthman I; Aoun J; Saad Aldin E; Merashli M; Khamashta MA
    Rheumatology (Oxford); 2013 Aug; 52(8):1358-67. PubMed ID: 23502076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
    Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
    Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
    Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
    Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLC immunostaining for detection of "antiphospholipid" antibodies.
    Conti F; Alessandri C; Spinelli FR; Capozzi A; Martinelli F; Recalchi S; Misasi R; Valesini G; Sorice M
    Methods Mol Biol; 2014; 1134():95-101. PubMed ID: 24497357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's Issues in Antiphospholipid Syndrome.
    Papadakis E; Banti A; Kioumi A
    Isr Med Assoc J; 2016 Sep; 18(9):524-529. PubMed ID: 28471597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early endosome as a pathogenic target for antiphosphatidylethanolamine antibodies.
    Hou S; Fölsch H; Ke K; Cook Mills J; Ramsey-Goldman R; Zhao M
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13798-13803. PubMed ID: 29229837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
    Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
    Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.